Why Is Ridgetech (NASDAQ:RDGT) Retreating 7.96% Before the Open on Tuesday?

Vinay Lochav

10 November 2026 11:44 PM AEDT

Why Is Ridgetech (NASDAQ:RDGT) Retreating 7.96% Before the Open on Tuesday?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Ridgetech (NASDAQ:RDGT) was indicated at USD 1.04 pre-market on November 10, 2026, lower by 7.96% against a calculated prior close of USD 1.13, a drop of around USD 0.09 per share.
A published quote page showed Market Value near USD 4.17 million, Volume of 283,990 shares against an average of 245,040, and a day range of USD 0.96 to USD 1.20.
The same page listed a 52-week low of USD 0.67 and a 52-week high of USD 760.50, a spread consistent with a share consolidation or a data error.
Ridgetech, formerly China Jo-Jo Drugstores, reported Revenue of USD 119.9 million and a loss of USD 2.0 million for the period ended September 30, 2025.

What Drove Ridgetech Lower Before the Open (-7.96%)

The screener snapshot taken before the open on November 10, 2026 shows Ridgetech (NASDAQ:RDGT) at USD 1.04, down 7.96%. Back-calculating gives a Monday, November 9 close near USD 1.13, a gap of USD 0.09. The company is a Hangzhou-based distributor of pharmaceutical and healthcare products in China, with retail drugstore, online pharmacy and drug wholesale segments. It changed its name in February 2024. A published quote page put the open at USD 1.11 and the intraday range at USD 0.96 to USD 1.20, a 25% spread between low and high (calculated), so a fall of 7.96% sits well inside normal intraday movement for this stock.

The Reasoning: Catalyst Versus General Mechanisms

No catalyst has been identified in published coverage dated November 9 or November 10, 2026. Recent published items include the naming of board chair Lingtao Kong as chief executive officer, and a completed securities offering of USD 2.8 million. Neither is dated to November 9 or November 10 in what we found, so neither is confirmed as the cause. As general background, a small offering adds shares and can pressure the price, while a Leadership change can shift sentiment either way. Foreign small caps on Nasdaq also move on reverse split announcements, minimum bid price notices and delisting warnings, each of which can set off rapid selling.

Valuation, Liquidity and Risks

With market value near USD 4.17 million and a USD 1.04 quote, the implied share count is about 4.0 million (calculated), a small float. Revenue of USD 119.9 million against that value gives a price to sales ratio near 0.03 (calculated), though the revenue period ended September 30, 2025 and may be stale. Pre-market spreads can reach 5 to 10 cents, and 9 cents equals 7.96% here. Dilution from the USD 2.8 million raise, Nasdaq minimum bid rules, regulatory and currency exposure in China, and a Reversal at the 9:30 a.m. ET open are the main risks. An early decline says nothing about the regular session.

Where Things Stand

Ridgetech (NASDAQ:RDGT) is retreating 7.96% pre-market on Tuesday, November 10, 2026, and no catalyst was identified in published coverage. The indicated USD 1.04 compares with a calculated USD 1.13 prior close. A recent chief executive change and a USD 2.8 million offering give background, but neither is confirmed as the trigger. With market value near USD 4.17 million, small trades can swing the price. Compare volume with the 245,040 average, check for any exchange notice, and watch the 9:30 a.m. ET open, since a 9 cent swing equals 7.96%.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.